| Literature DB >> 24265746 |
Emily S W Wong1, Stewart Nicol, Wesley C Warren, Katherine Belov.
Abstract
Monotremes (echidna and platypus) are egg-laying mammals. One of their most unique characteristic is that males have venom/crural glands that are seasonally active. Male platypuses produce venom during the breeding season, delivered via spurs, to aid in competition against other males. Echidnas are not able to erect their spurs, but a milky secretion is produced by the gland during the breeding season. The function and molecular composition of echidna venom is as yet unknown. Hence, we compared the deeply sequenced transcriptome of an in-season echidna crural gland to that of a platypus and searched for putative venom genes to provide clues into the function of echidna venom and the evolutionary history of monotreme venom. We found that the echidna venom gland transcriptome was markedly different from the platypus with no correlation between the top 50 most highly expressed genes. Four peptides found in the venom of the platypus were detected in the echidna transcriptome. However, these genes were not highly expressed in echidna, suggesting that they are the remnants of the evolutionary history of the ancestral venom gland. Gene ontology terms associated with the top 100 most highly expressed genes in echidna, showed functional terms associated with steroidal and fatty acid production, suggesting that echidna "venom" may play a role in scent communication during the breeding season. The loss of the ability to erect the spur and other unknown evolutionary forces acting in the echidna lineage resulted in the gradual decay of venom components and the evolution of a new role for the crural gland.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24265746 PMCID: PMC3827146 DOI: 10.1371/journal.pone.0079092
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Monotremes and their crural glands.
1) An echidna (image taken from http://faunafemales.wikispaces.com/Echidna) and a dissected crural gland-spur apparatus from an adult male echidna. Photo was taken by William Krause and reprinted with permission from reference 2. Note that the main duct linking the crural gland and spur is shorter in the echidna than in the platypus. The spur (highlighted by an arrow) is not able to be erected in the echidna. 2) A platypus (image taken from http://faunafemales.wikispaces.com/Platypuses) and a dissected gland-spur apparatus taken from an adult male platypus. The original photograph was published by Krause in reference 2 (licence number 3184480567659).
Figure 2Schematic of bioinformatics workflow for the assembly, annotation and quantitation of echidna transcripts.
Echidna transcripts that display higher similarity to known toxins than human proteins.
| Toxin name | Transcript locus number | Expression rank (out of 91,300) |
| Stonustoxin subunit alpha (Acc: Q98989) | 726, 11716 | 24,455 |
| Platypus CD55/complement decay accelerating factor (Acc: K4PB89) | 2792, 50224 | 42,570 |
| Platypus amide oxidase (Acc: K4P911) | 8792, 18049 | 71,866 |
| Snake venom nerve growth factor 2 ( | 11196 | 36,479 |
| Snake venom nerve growth factor ( | 11197 | 20,498 |
| Platypus corticotrophin-releasing factor binding protein (Acc: K4PLU9) | 11716 | 79,938 |
| Platypus Kunitz domain containing protease inhibitor | 16527 | 61,251 |
| Sea anemone Kunitz domain containing protease inhibitor (Acc: Q9TWG0) | 16966 | 41,527 |
| Snake mulgin-3 protease inhibitor ( | 16966, 47678 | 35,771 |
| Platypus cysteine-rich secretory protein (Acc: K4P991) | 40579 | 51,113 |
| Snake venom phospholipase A2 ( | 43122 | 53,680 |
| Snake venom phospholipase A2 trimucrotoxin ( | 49881 | 83,368 |
The name of the known toxin together with the echidna transcript number and ranking of mRNA expression level are shown (a higher ranking indicates higher expression levels relative to other transcripts in the echidna transcriptome).
Known platypus venom proteins and their homologs in the echidna transcriptome.
| Platypus toxin | Ancestral activity | Derived activity | Expressed in echidna gland |
| Defensin-likepeptides | Antimicrobial | Unknown | No |
| Nerve growthfactor | Regulation of nerve growth and differentiation; Hyperalgaesia | Possibly hyperalgaesia | No |
| C-type natriureticpeptide-like | Natriuretic, diuretic and vasodilatory functions associatedwith homeostasis and blood pressure control andregulates the growth and differentiation ofcartilaginous growth plate chondrocytes | Relaxant, oedema-producing andmast-cell degranulatingactivities | No |
| Hyaluonidase | Increase tissue permeability by lowering the viscosity of hyaluronan– roles in reproduction | Believed to accelerate the spread oftoxins and hemostatic factorsin toxin | No |
| Amide oxidase | Function in cell differentiation, growth, wound healing,detoxification, cell signaling | May cause platelet aggregation,assist in haemorrhage andcell death | Yes |
| Peptidoglycanrecognitionprotein-1 | Antimicrobial | Unknown | No |
| Serpin | Blood coagulation, complement activation, fibrinolysis,angiogenesis, inflammation, tumour suppression andhormone transport | Possible role in blood coagulationand hypertension | No |
| Kunitz-domaincontaining serineprotease inhibitor | Involved in hemostasis | Possible role in disrupting hemostasis | Yes |
| Nucleobindin | Stimulates autonomic nervous system activity, increasesblood pressure, induces fear in rats | May induce the fear response in victim | No |
| Differentiationfactor-15 | Regulates the inflammatory response and apoptosis | May function to induce pain | No |
| CXC-chemokine | Chemotactic, mediate cell growth and triggers aninflammatory response | Unknown | No |
| Complement decay-acceleration factor | Inhibits complement-mediated lysis | Unknown | Yes |
| L-D-amino-acid-residue isomerase | Unknown | Interconverts the second amino-acidresidue of venom peptides betweenthe L-form and D-form | No |
| Corticotropin-releasingfactor-binding protein | Linked to behavioural and psychological changes andnerve signalling | Suggested to increase submissive behaviourin victim linked to role of venomfor intraspecific competition | Yes |
The most highly expressed proteins in the echidna transcriptome as annotated by platypus Ensembl proteins.
| Transcript reference number | Platypus Ensembl accession | Gene name | Description | RPKM |
| 968 | ENSOANG00000011369 | BCHE | butyrylcholinesterase | 604 |
| 8337 | ENSOANG00000005594 | SLC25A3 | solute carrier family 25 (mitochondrial carrier) | 441 |
| 1723 | ENSOANG00000009799 | CALR | calreticulin | 433 |
| 15082 | ENSOANG00000012964 | EEF1B2 | eukaryotic translation elongation factor 1 beta 2 | 421 |
| 1219 | ENSOANG00000013689 | – | – | 400 |
| 1766 | ENSOANG00000003422 | LTV1 | unknown function | 378 |
| 656 | ENSOANG00000011189 | RPS27A | ribosomal protein S27a | 376 |
| 6048 | ENSOANG00000000439 | – | – | 371 |
| 3603 | ENSOANG00000010996 | PDCD10 | programmed cell death 10 | 367 |
| 871 | ENSOANG00000008043 | – | – | 366 |
Gene ontology (GO) terms that were enriched in the top 200 most highly expressed echidna genes compared to the platypus using GoStat2.
| GOterm | GOname | Echidna genesin group | Adjustedp-value |
| GO:0032559 | adenylribonucleotide binding | chuk; supv3l1; lars; igf1r; helz; tarsl2; tpr; atp2c1; dhx29; wee1;crebbp; smarca1; dhx36; dync1h1; hspa4; smchd1;dync1li1; tcn1; myo10; smarca5; taok1; atp2a2;abl1; ndufa10; trio; atp2b1; ddx50; top2b; afg3l2;hnrnpu; kif5b; ddx6 | 0.0159 |
| GO:0030554 | adenylnucleotide binding | chuk; supv3l1; lars; igf1r; helz; tarsl2; tpr; atp2c1;dhx29; wee1; crebbp; smarca1; dhx36; dync1h1;hspa4; smchd1; dync1li1; tcn1; myo10; smarca5;taok1; atp2a2; abl1; ndufa10; trio; atp2b1; ddx50;top2b; afg3l2; hnrnpu; kif5b; ddx6 | 0.0159 |
| GO:0005524 | ATPbinding | chuk; supv3l1; lars; igf1r; helz; tarsl2; tpr; atp2c1;dhx29; wee1; crebbp; smarca1; dhx36; dync1h1;hspa4; smchd1; dync1li1; tcn1; myo10;smarca5; taok1; atp2a2; abl1; ndufa10; trio;atp2b1; ddx50; top2b; afg3l2; hnrnpu; kif5b; ddx6 | 0.0159 |
| GO:0043687 | post-translationalprotein modification | chuk; mgrn1; cnot4; abl1; usp14; igf1r; trio; ppp2ca;dsp; rb1cc1; twf1; ube2d2; prdx4; march7; wee1;wwp2; crebbp; cul4b; ighm; huwe1; ppp1cc; ppp3ca;ccdc88c; march6; taok1 | 0.0257 |
| GO:0044459 | plasmamembrane part | clcn4; atp2a2; igf1r; slc12a7; mpp1; cltc; dsp;rab5a; cyfip1; enpp3; slc4a4; atp2b1; dtna;apc; calr; cp; cdh1; ighm; tjp1; itgb1; slc7a8; slc25a3 | 0.0843 |
Threshold at adjusted p-value<0.1.